Buscar resultados de ensayos clínicos

Patrocinado por

Adenocarcinoma of the Appendix - 23 Studies Found

Estado Estudiar
Active, not recruiting Nombre del estudio: Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Condición: Advanced GI Cancer
Fecha: 2014-10-15
Intervenciones: Drug: MK-3475 MK-3475 in combination with mFOLFOX6 in a 14
Active, not recruiting Nombre del estudio: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Condición:
  • Mucinous Adenocarcinoma of the Colon
  • Muci
    Fecha: 2012-07-25
    Intervenciones:
    • Biological: aflibercept 4 mg/k
Withdrawn Nombre del estudio: Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
Condición:
  • Mucinous Adenocarcinoma of the Colon
  • Muci
    Fecha: 2011-07-25
    Intervenciones:
    • Dietary Supplement: cholecalciferol

Terminated Nombre del estudio: Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
Condición:
  • Mucinous Adenocarcinoma of the Rectum
  • Stage IIA Rectal Cancer Fecha: 2010-09-02
    Intervenciones:
    • Drug: paricalcitol Given PO
Withdrawn Nombre del estudio: Research Study in Patients With Advanced Ovarian Epithelial Cancer
Condición:
  • Ovarian Serous Cystadenocarcinoma
  • Ovarian Serous Surface Papill
    Fecha: 2003-01-27
    Intervenciones:
    • Genetic: Comparative Genomic Hybridization

Active, not recruiting Nombre del estudio: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Condición:
  • Fallopian Tube Clear Cell Adenocarcinoma
  • Fallopian Tube Endometrioid Adenocarcinoma
    • Fecha: 2010-02-23
    Intervenciones:
    • Drug: Bortezomib Given IP
Terminated Nombre del estudio: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
Condición:
  • Malignant Ovarian Mixed Epithelial Tumor
  • Ovarian Clear Cell Cystadenoc
    Fecha: 2000-01-28
    Intervenciones:
    • Drug: Carboplatin Given IV
Completed Nombre del estudio: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
Condición:
  • Brenner Tumor
  • Ovarian Clear Cell Cystadenocarcinoma
  • Fecha: 1999-11-01
    Intervenciones:
    • Drug: paclitaxel Given IV
Active, not recruiting Nombre del estudio: Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
Condición:
  • Fallopian Tube Cancer
  • Ovarian Clear Cell Cystadenocarcinoma Fecha: 2006-07-26
    Intervenciones:
    • Biological: denileukin diftitox

Completed Nombre del estudio: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Condición:
  • Malignant Ovarian Mixed Epithelial Tumor
  • Ovarian Brenner Tumor
  • Drug: TLR8 Agonist VTX-2337 Gi
<<< Previous | Next >>>